Results 151 to 160 of about 5,903 (182)
Clonal diversity of carbapenemase-producing Pseudomonas aeruginosa isolated from clinical samples in a third level hospital in Peru. [PDF]
Rev Peru Med Exp Salud PublicaSalvador-Lujan G +5 more
europepmc +1 more source
Rapid AST: Possibility of inferring resistance mechanisms with complex phenotypes. [PDF]
Rev Esp QuimioterLigero-López J +5 more
europepmc +1 more source
Susceptibilidad a ceftolozano-tazobactam y ceftazidima-avibactam de Pseudomonas aeruginosa resistente a carbapenémicos [PDF]
Revista Del Instituto De Salud Pública De Chile, 2021 Pseudomonas aeruginosa ha sido considerada por la Organización Mundial de la Salud (OMS) de importancia para la investigación de nuevos antibióticos. Revisamos la susceptibilidad in vitro y la producción de carbapenemasas de ceftolozano-tazobactam (C-T) y ceftazidima-avibactam (CZA), a P. aeruginosa no susceptible a carbapenémicos.
Claudia Elena Guajardo-Lara +3 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Trombocitopenia inducida por ceftazidima
Revista Española De Anestesiología Y Reanimación, 2017Ceftazidime is an antibiotic belonging to the group of third generation cephalosporins, frequently used in clinical practice for its broad antibacterial spectrum. A case report is presented on a 78-year-old man who entered the intensive care unit due to respiratory failure secondary to nosocomial pneumonia in the postoperative period of a laparoscopic ...
E. Domingo-Chiva +5 more
exaly +2 more sources
6ER-023 Study of the use of ceftazidima-avibactam in a third-level university hospital
Section 6: Education and research, 2022I De La Fuente Villaverde +9 more
exaly +2 more sources